China Pharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	31	19	8	6	7	23
Market Cap Growth	304.75%	147.12%	18.23%	-10.61%	-68.52%	12.44%
Enterprise Value	34.56	19.98	9.49	8.46	11.42	25.97
Last Close Price	0.77	1.21	2.33	6.05	48.00	241.30
PS Ratio	7.81	4.53	1.68	0.92	0.89	2.37
PB Ratio	0.84	0.83	0.98	0.86	1.68	3.80
P/TBV Ratio	0.21	0.23	0.53	0.28	1.18	3.70
P/FCF Ratio	188.15	211.18	-	-	-	-
P/OCF Ratio	187.02	126.68	-	-	-	-
EV/Sales Ratio	8.66	4.82	2.10	1.21	1.41	2.69
EV/EBITDA Ratio	-	-	-	4617.81	-	114.25
EV/FCF Ratio	208.61	224.69	-	-	-	-
Debt / Equity Ratio	0.04	0.07	0.33	0.47	1.46	1.34
Debt / EBITDA Ratio	-	-	-	2528.11	-	54.94
Debt / FCF Ratio	23.76	40.43	-	-	-	-
Net Debt / Equity Ratio	0.09	0.14	0.38	0.42	1.57	1.25
Net Debt / EBITDA Ratio	-2.35	-1.96	-1.54	1715.36	-7.91	33.16
Net Debt / FCF Ratio	22.63	36.55	-6.63	-4.42	-8.27	-10.96
Asset Turnover	0.10	0.18	0.29	0.41	0.40	0.44
Inventory Turnover	2.37	2.20	2.17	2.18	2.73	2.64
Quick Ratio	0.06	0.09	0.18	0.32	0.20	0.54
Current Ratio	0.28	0.32	0.65	0.88	0.47	0.86
Return on Equity (ROE)	-11.86%	-20.91%	-62.31%	-52.43%	-77.08%	-48.49%
Return on Assets (ROA)	-9.45%	-14.12%	-29.27%	-16.07%	-17.55%	-13.07%
Return on Invested Capital (ROIC)	-8.56%	-12.71%	-28.51%	-13.93%	-15.32%	-11.76%
Return on Capital Employed (ROCE)	-11.70%	-19.36%	-47.02%	-37.46%	-41.31%	-26.18%
FCF Yield	0.53%	0.47%	-	-	-	-
Buyback Yield / Dilution	-343.17%	-145.73%	-416.13%	-221.82%	-13.96%	-5.74%
Total Shareholder Return	-343.17%	-145.73%	-416.13%	-221.82%	-13.96%	-5.74%

SEC Filings: 10-K · 10-Q